↓ Skip to main content

Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis

Overview of attention for article published in Drug Development & Industrial Pharmacy, May 2019
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis
Published in
Drug Development & Industrial Pharmacy, May 2019
DOI 10.1080/03639045.2019.1609494
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 5 13%
Student > Ph. D. Student 3 8%
Student > Doctoral Student 2 5%
Student > Bachelor 2 5%
Student > Master 2 5%
Other 7 18%
Unknown 18 46%
Readers by discipline
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 7 18%
Medicine and Dentistry 3 8%
Biochemistry, Genetics and Molecular Biology 2 5%
Agricultural and Biological Sciences 2 5%
Chemistry 2 5%
Other 3 8%
Unknown 20 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2019.
All research outputs
#28,617,732
of 34,377,743 outputs
Outputs from Drug Development & Industrial Pharmacy
#2,183
of 2,610 outputs
Outputs of similar age
#315,840
of 395,128 outputs
Outputs of similar age from Drug Development & Industrial Pharmacy
#9
of 10 outputs
Altmetric has tracked 34,377,743 research outputs across all sources so far. This one is in the 9th percentile – i.e., 9% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,610 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 4th percentile – i.e., 4% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 395,128 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one.